Greenwood Capital Associates LLC boosted its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 759.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,714 shares of the company’s stock after buying an additional 20,955 shares during the period. Greenwood Capital Associates LLC’s holdings in Procter & Gamble were worth $4,107,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also bought and sold shares of PG. Itau Unibanco Holding S.A. bought a new position in Procter & Gamble in the 2nd quarter worth about $28,000. Fairway Wealth LLC purchased a new stake in shares of Procter & Gamble in the second quarter worth about $29,000. Ruedi Wealth Management Inc. boosted its position in shares of Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the period. POM Investment Strategies LLC purchased a new position in Procter & Gamble during the second quarter valued at approximately $34,000. Finally, Quest Partners LLC bought a new stake in Procter & Gamble during the 2nd quarter worth approximately $36,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Price Performance
Shares of Procter & Gamble stock opened at $165.08 on Tuesday. The company’s fifty day simple moving average is $171.52 and its two-hundred day simple moving average is $168.13. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The firm has a market cap of $388.77 billion, a PE ratio of 28.46, a price-to-earnings-growth ratio of 3.57 and a beta of 0.42. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.44%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s payout ratio is currently 69.48%.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the company’s stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares in the company, valued at approximately $1,954,538.34. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Procter & Gamble news, CEO Jon R. Moeller sold 72,174 shares of the company’s stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the sale, the chief executive officer now owns 263,158 shares in the company, valued at approximately $45,002,649.58. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares of the company’s stock, valued at $1,954,538.34. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 385,771 shares of company stock valued at $65,610,975. Company insiders own 0.18% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on PG. DA Davidson upped their price target on shares of Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a report on Monday, October 21st. JPMorgan Chase & Co. boosted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Stifel Nicolaus lifted their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research report on Monday, July 22nd. StockNews.com cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Hsbc Global Res upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $177.00.
View Our Latest Analysis on Procter & Gamble
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Rise of AI Agents vs. RPA Bots: 3 Stocks to Watch Now
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Merck vs. Bristol-Myers: Analyst Views Differ After Q3 Earnings
- How to Plot Fibonacci Price Inflection Levels
- Intel: Is Now the Time to Be Brave?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.